Bharat Parenterals Ltd
Bharat Parenterals Ltd (BPLPHARMA) last reported results for the quarter ended Jun 2026, with sales of ₹93.74 crore and net profit of ₹-3.56 crore. Bharat Parenterals Ltd’s board meets on 23 Oct 2026. The stock last traded at ₹1,777, a market capitalisation of ₹1,225 crore. Over the past 52 weeks the stock has ranged between ₹880 and ₹2,278. Figures are as of 6 Oct 2026 and are not real time.
Bharat Parenterals Ltd share price and key metrics
- Current price
- ₹1,777
- Market cap
- ₹1,225 cr
- Book value
- ₹468
- ROE
- -2.54%
- ROCE
- -1.87%
- Dividend yield
- 0.06%
- 52w high / low
- 2278/880
Metrics as of 6 Oct 2026. Not real time.
Track Bharat Parenterals Ltd
Cruxal reads every Bharat Parenterals Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Bharat Parenterals Ltd growth and returns
- 10 Years
- 11%
- 5 Years
- 11%
- 3 Years
- 17%
- TTM
- -11%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- TTM
- -172%
- 10 Years
- %
- 5 Years
- 36%
- 3 Years
- 45%
- 1 Year
- 34%
- 10 Years
- 7%
- 5 Years
- 3%
- 3 Years
- -1%
- Last Year
- -3%
Bharat Parenterals Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹93.74 cr, down 19.2% from ₹116 cr a year earlier. Net profit was ₹-3.56 cr, down 309.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 71.63 | 72.26 | 104 | 116 | 64.62 | 65.19 | 99.62 | 93.74 |
| Expenses | 79.29 | 68.62 | 102 | 102 | 63.79 | 63.45 | 100 | 85.21 |
| Operating profit | -7.66 | 3.64 | 2.23 | 13.78 | 0.83 | 1.74 | -0.52 | 8.53 |
| OPM % | -10.69% | 5.04% | 2.14% | 11.88% | 1.28% | 2.67% | -0.52% | 9.10% |
| Other income | 4.21 | 2.94 | 1.93 | 1.06 | 3.53 | 1.33 | 3.63 | 1.11 |
| Interest | 2.91 | 3.33 | 3.94 | 3.69 | 3.11 | 2.9 | 2.85 | 2.45 |
| Depreciation | 9.01 | 8.76 | 8.52 | 8.6 | 8.56 | 8.46 | 8.63 | 8.69 |
| Profit before tax | -15.37 | -5.51 | -8.3 | 2.55 | -7.31 | -8.29 | -8.37 | -1.5 |
| Tax % | 13.92% | 43.01% | 13.61% | 133.73% | 17.65% | 16.77% | -2.51% | 138.00% |
| Net profit | -17.51 | -7.88 | -9.44 | -0.87 | -8.6 | -9.67 | -8.16 | -3.56 |
| EPS (₹) | -11.50 | -2.42 | -6.86 | 11.94 | -10.49 | -6.37 | -6.96 | 1.47 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Bharat Parenterals Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 111 | 137 | 220 | 228 | 205 | 212 | 218 | 261 | 340 | 345 | 323 |
| Operating profit | 7 | 12 | 29 | 28 | 25 | 29 | 20 | 27 | 4 | 16 | 11 |
| OPM % | 6% | 9% | 13% | 12% | 12% | 14% | 9% | 10% | 1.1% | 4.6% | 3.3% |
| Net profit | 7 | 9 | 21 | 24 | 20 | 21 | 16 | 11 | -44 | -27 | -30 |
| EPS (₹) | 12.03 | 15.92 | 37.09 | 42.13 | 35.59 | 36.45 | 28.47 | 24.95 | -18.33 | -11.88 | -22.35 |
TTM is the trailing twelve months to the most recent quarter.
Bharat Parenterals Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Reserves | 58 | 67 | 88 | 112 | 138 | 160 | 177 | 191 | 324 | 315 |
| Borrowings | 6 | 9 | 5 | 1 | 12 | 18 | 50 | 158 | 180 | 146 |
| Other liabilities | 40 | 50 | 60 | 68 | 43 | 42 | 118 | 149 | 138 | 145 |
| Total liabilities | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |
| Fixed assets | 31 | 34 | 35 | 33 | 45 | 41 | 42 | 211 | 252 | 255 |
| CWIP | 0 | 0 | 1 | 12 | 0 | 26 | 99 | 25 | 31 | 35 |
| Investments | 1 | 1 | 1 | 0 | 43 | 11 | 0 | 0 | 5 | 6 |
| Other assets | 79 | 98 | 121 | 142 | 111 | 148 | 209 | 268 | 360 | 317 |
| Total assets | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |
As reported by the company. Total assets equal total liabilities by construction.
Bharat Parenterals Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -2 | 6 | 20 | 14 | 24 | -1 | 22 | -5 | -27 | 38 |
| Cash from investing | -2 | -8 | -9 | -13 | -43 | -7 | -78 | -105 | -137 | 9 |
| Cash from financing | -8 | 4 | -4 | -3 | 10 | 9 | 61 | 110 | 156 | -47 |
| Net cash flow | -11 | 2 | 7 | -1 | -8 | 2 | 4 | 1 | -8 | 1 |
| Free cash flow | -4 | -2 | 12 | -0 | 24 | -40 | -68 | -108 | -56 | -1 |
| CFO / operating profit | -8% | 73% | 107% | 87% | 123% | 16% | 150% | 18% | -444% | 305% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Bharat Parenterals Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 11% | 18% | 39% | 31% | 20% | 17% | 11% | 7% | -4% | -2% |
| Debtor days | 143 | 157 | 106 | 127 | 121 | 126 | 188 | 198 | 184 | 159 |
| Inventory days | 70 | 60 | 59 | 71 | 61 | 56 | 100 | 142 | 132 | 162 |
| Days payable | 168 | 110 | 83 | 104 | 71 | 64 | 136 | 137 | 136 | 122 |
| Cash conversion cycle | 45 | 107 | 82 | 93 | 111 | 118 | 152 | 202 | 180 | 199 |
| Working capital days | 64 | 78 | 73 | 89 | 106 | 148 | 91 | 81 | 76 | 143 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Bharat Parenterals Ltd shareholding pattern
Promoters held 67.20% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.11% and DIIs 1.38%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 65.35% | 67.20% | 67.20% | 67.19% | 67.19% | 67.19% | 67.17% | 67.20% |
| FIIs | 0.08% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| DIIs | 0.57% | 0.54% | 0.54% | 0.54% | 0.54% | 0.54% | 1.07% | 1.38% |
| Public | 33.98% | 32.16% | 32.15% | 32.16% | 32.16% | 32.17% | 31.65% | 31.31% |
| No. of shareholders | 2,748 | 3,116 | 3,177 | 3,231 | 3,205 | 3,172 | 3,095 | 3,059 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When does Bharat Parenterals Ltd’s board next meet?
Bharat Parenterals Ltd’s board meets on 23 Oct 2026.
- Board meetingApproval of preferential issue of equity shares to proposed allottees
- AGMApproval of financial statements and other resolutions
See the full results calendar for every Indian company reporting in the next 30 days.
Bharat Parenterals Ltd corporate filings
- Compliance Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026Company Updatelow impact
- Bharat Parenterals Limited schedules EGM on October 23, 2026, to approve corporate actionsCompany Updatemedium impact
Cruxal's analysis: Bharat Parenterals Limited has announced an Extraordinary General Meeting (EGM) scheduled…
Read the full analysis - Regulatory and Strategic Corporate Actions Indicate Significant Capital Raising and Investment PlansAGM/EGMhigh impact
Cruxal's analysis: Bharat Parenterals Limited is undertaking a substantial capital raise through a…
Read the full analysis - Outcome of the board meeting for the board approves the Preferential AllotmentBoard Meetingmedium impact
- Intimation for the closure of the trading Window in terms of the SEBI (Prohibition of Insider Trading) Regulations, 2015Insider Trading / SASTlow impact
- Bharat Parenterals Limited announces board meeting to consider preferential issue of equity sharesBoard Meetinghigh impact
Cruxal's analysis: Bharat Parenterals Limited has scheduled a board meeting for September 29, 2026, to…
Read the full analysis - Bharat Parenterals Limited concludes 33rd AGM; shareholders approve financial statements, dividend, and director re-appointmentAGM/EGMlow impact
Cruxal's analysis: Bharat Parenterals Limited has successfully concluded its 33rd Annual General Meeting…
Read the full analysis - Bharat Parenterals Limited Concludes 33rd Annual General Meeting; Adopts Financials and Re-appoints Executive DirectorAGM/EGMlow impact
Cruxal's analysis: Bharat Parenterals Limited has successfully concluded its 33rd Annual General Meeting…
Read the full analysis - Bharat Parenterals Ltd issues public notice for newspaper advertisementCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has released a public notice for a newspaper advertisement dated…
Read the full analysis - Bharat Parenterals Ltd schedules 33rd Annual General Meeting for September 19, 2026Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has published newspaper notices regarding the scheduling of its…
Read the full analysis - Bharat Parenterals Ltd issues notice to shareholders for FY 2025-26 Annual Report accessCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has dispatched letters to shareholders whose email addresses are…
Read the full analysis - Bharat Parenterals Limited fixes September 12, 2026 as Record Date for FY 2025-26 dividendCorp. Actionlow impact
Cruxal's analysis: Bharat Parenterals Limited has announced September 12, 2026, as the record date to…
Read the full analysis - Bharat Parenterals Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Bharat Parenterals Ltd has filed its Annual Report for the financial year 2025-26. The…
Read the full analysis - Bharat Parenterals Limited Announces 33rd AGM, Dividend Declaration, and Executive Director Re-appointmentAGM/EGMmedium impact
Cruxal's analysis: Bharat Parenterals Limited has scheduled its 33rd Annual General Meeting for September…
Read the full analysis - Bharat Parenterals Ltd announces pre-newspaper advertisement for 33rd Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has issued a formal intimation regarding the publication of a…
Read the full analysis - Bharat Parenterals Ltd receives approval for trading of equity shares on the National Stock Exchange (NSE)Company Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has received formal intimation regarding the permission to trade…
Read the full analysis - Bharat Parenterals Ltd issues newspaper notice for re-lodging of physical share transfer deedsCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has published a newspaper notice to inform physical shareholders…
Read the full analysis - Bharat Parenterals announces expansion and facility enhancement of subsidiary Varenyam BiolifesciencesCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Limited has issued a press release regarding the expansion and…
Read the full analysis - Bharat Parenterals Ltd schedules analyst and investor meetingCompany Updatelow impact
Cruxal's analysis: Bharat Parenterals Ltd has issued an intimation regarding an upcoming analyst and…
Read the full analysis - Bharat Parenterals Limited reports Q1 FY2027 financial results with net loss of 3.56 croreCompany Updatemedium impact
Cruxal's analysis: Bharat Parenterals Limited has released its unaudited financial results for the quarter…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.